Streetbeat News

Products Services

TRIB

Trinity Biotech (NASDAQ:TRIB) stock surged due to increased orders for TrinScreen HIV, raising 2024 sales expectations to $10 million. The company also expanded production for its viral transport medium, FlexTrans, amid rising demand. TRIB reported a 14% YoY revenue increase in Q2, driven by TrinScreen HIV sales.

Portfolio Pulse from Vandana Singh

August 27, 2024 | 12:55 pm

MA

Rellevate and Mastercard have partnered to enhance digital payment capabilities in the U.S. public sector, focusing on financial inclusion and efficient money management for underserved communities.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:55 pm

AAPL

Apple is set to launch the AI-enabled iPhone 16, marking its biggest upgrade cycle, with expectations of over 90 million initial shipments. Analyst Daniel Ives predicts this will drive Apple's market cap past $4 trillion. The transition of CFO from Luca Maestri to Kevan Parekh is expected to be smooth.

Portfolio Pulse from Shanthi Rexaline

August 27, 2024 | 12:50 pm

ADXN

INDV

JNJ

Addex Therapeutics and Indivior have selected a compound for substance use disorder treatment, with Addex eligible for up to $330 million in milestone payments. Addex will also advance its own compound for chronic cough. Previously, Janssen Pharmaceuticals, a Johnson & Johnson unit, discontinued a compound for epilepsy.

Portfolio Pulse from Vandana Singh

August 27, 2024 | 12:48 pm

BIVI

BioVie presented data on Bezisterim at the Aging Research and Drug Discovery Meeting, highlighting its potential in addressing inflammation and aging-related disorders.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:46 pm

ELTK

Eltek has received orders totaling $3.5 million from two defense customers, indicating strong demand for its products in the defense sector.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:41 pm

ZLAB

Zai Lab Limited will present preliminary data from its Phase 1 trial of ZL-1218, an anti-CCR8 antibody, at the ESMO Congress 2024. The study focuses on the treatment of advanced solid tumors and highlights the potential of ZL-1218 to modulate the tumor microenvironment and regulate anticancer immune response.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:41 pm

CLPS

CLPS Incorporation has announced the grand opening of its wholly-owned Singapore-based learning institution, College of Allied Educators Pte. Ltd. This strategic move aims to vertically integrate CLPS's business with academic education.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:40 pm

ALSN

Allison Transmission has announced the successful deployment of its transmission in a Hyundai hydrogen fuel cell truck by GLS Germany, covering 30,000 kilometers and delivering 100,000 packages. This marks a significant step in testing eco-friendly logistics solutions.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 12:39 pm

LCID

RIVN

Rivian Automotive Inc. (RIVN) and Lucid Group Inc. (LCID) are two California-based EV startups investing heavily in R&D while yet to turn a profit. Rivian, with higher sales volume, reported a larger net loss compared to Lucid. Both companies are planning new models to expand their market reach. Rivian aims for profitability by late 2024, while Lucid has not provided a timeline. Year-to-date, Lucid's stock is up 2.7%, while Rivian's is down 32%.

Portfolio Pulse from Anan Ashraf

August 27, 2024 | 12:35 pm